AU markets
Biotech and healthcare company research across the US and Australia, covering drug development, medical devices, diagnostics and healthcare businesses. Explore articles on clinical milestones, regulatory announcements, commercial progress and financing. Coverage considers the distinction between a research milestone and an approved or commercially established product, alongside the risks and remaining steps described in each dated article.
22 results
Explore United States marketsAustralia · Company Research
A fall from A$0.044 to A$0.040 does not sound like much until the percentage does the talking. Immuron Limited (ASX:IMC) is down 9.09% from the open, based on…
Australia · Company Research
For a small biotech, clarity can be just as important as excitement. NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has spent the past year reshaping itself around StemSmart, a patented mesenchymal…
Australia · Company Research
Small-cap tech volatility has a way of returning quickly. dorsaVi Ltd (ASX:DVL) was one of the sharper names in the 11am ASX catch-up scan, with available public quote…
Australia · Company Research
Vitrafy Life Sciences (ASX:VFY) has moved from a quiet ASX healthcare name to one of the more closely watched small-cap life sciences stories on the market. The share…
Australia · Company Research
Small-cap healthcare rallies often begin with a single announcement. OncoSil Medical (ASX:OSL) gave the market three. The pancreatic cancer device company stood out on the ASX today after…
Australia · Company Research
LTR Pharma Ltd (ASX:LTP) gave traders a sharp reminder that clinical-stage healthcare stocks can move quickly in both directions. The LTR Pharma share price was down 8.7% from…
Australia · Company Research
There are biotech rallies that look like noise. Then there are rallies that arrive with a cleaner story attached. OncoSil Medical (ASX:OSL) landed in the second group after…
Australia · Company Research
HITIQ Limited (ASX:HIQ) rose 33.33% to A$0.012, a sharp one-day move for a company still trying to prove that its concussion technology can move from promise to commercial…
Australia · Company Research
Pro Medicus shares rose sharply as investors focused on cloud imaging contracts, scalable software margins and hospital adoption. Pro Medicus Shares Jump as Investors Focus on Cloud Imaging…
Australia · Company Research
ResMed (ASX:RMD, NYSE:RMD) is not being punished for a weak quarter. That is what makes the recent share price pressure more interesting. The sleep apnea device giant delivered…
